Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US shareholder suit another woe for KV Pharmaceutical

This article was originally published in Scrip

Executive Summary

Troubled times continue at KV Pharmaceuticalwith the news that a shareholder class action lawsuit has been filed against the company. The suit, lodged on December 2nd, alleges that KV violated US securities laws by making misleading claims about the manufacture and marketing of certain generics and inflating the value of its stock between February 15th, 2008 and November 12th, 2008. The suit seeks unspecified damages.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC007529

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel